Get startedLog in
    Picture of Kezar Life Sciences logo

    KZR — Kezar Life Sciences News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    All News

    Brief: Everest Medicines And Kezar Life Sciences Receive IND Approval From China NMPA For Palizade Trial In Lupus Nephritis

    Picture of Kezar Life Sciences logoKezar Life Sciences
    26/02/2024 23:12
    Feb 26 (Reuters) - Everest Medicines Ltd  1952.HK :
    * EVEREST MEDICINES AND KEZAR LIFE SCIENCES RECEIVE IND
APPROVAL
FROM CHINA NMPA FOR PALIZADE TRIAL IN LUPUS NEPHRITIS

Source text for Eikon:  ID:nPnrjtP3a 
Further company coverage:  1952.HK 

 ((reuters.briefs@thomsonreuters.com;))

    Recent news on Kezar Life Sciences

    See all news